Mangalam Drugs & Organics Limited
NSE: MANGALAM BSE: MANGALAM
Prev Close
33.87
Open Price
35.25
Volume
142,505
Today Low / High
32.41 / 35.4
52 WK Low / High
22.8 / 95
Range
32 - 35
Prev Close
33.98
Open Price
35.55
Volume
31,969
Today Low / High
32.66 / 35.55
52 WK Low / High
22.7 / 116
Range
32 - 35
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 33.21 (target range: 32 - 35), reflecting a change of -0.66 (-1.94863%). On the BSE, it is listed at 33.17 (target range: 32 - 35), showing a change of -0.81 (-2.38376%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Mangalam Drugs & Organics Limited Graph
Mangalam Drugs & Organics Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Mangalam Drugs & Organics Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 33.21, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 33.17 | 33.50 | 30.15 - 36.85 |
| 33.83 | 27.07 - 40.60 | ||
| 34.17 | 23.92 - 44.41 | ||
| Bearish Scenario | 33.17 | 32.84 | 29.55 - 36.12 |
| 32.51 | 26.01 - 39.01 | ||
| 32.17 | 22.52 - 41.83 |
Overview of Mangalam Drugs & Organics Limited
ISIN
INE584F01014
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
163,212
Market Cap
441,291,554
Last Dividend
0
Official Website
IPO Date
2005-05-23
DCF Diff
51.35
DCF
-23
Financial Ratios Every Investor Needs
Stock Dividend of MANGALAM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2017-12-21 | December 21, 17 | 0.5 | 0.5 | 2017-12-22 | 2017-12-29 | 2017-12-12 |
| 2011-09-20 | September 20, 11 | 2 | 2 | |||
| 2006-09-19 | September 19, 06 | 0.2 | 0.2 | |||
| 2005-08-30 | August 30, 05 | 0.2 | 0.2 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 317.58 Cr | 167.37 Cr | 150.21 Cr | 0.4730 | 3.47 Cr | 40.59 Cr | 17.40 Cr | 6.72 Cr | 4.25 | 36.33 Cr | 0.0212 |
| 2024-03-31 | 367.35 Cr | 348.54 Cr | 18.81 Cr | 0.0512 | 3.27 Cr | 9.51 Cr | 1.06 Cr | -9.07 Cr | -5.73 | 17.49 Cr | -0.0247 |
| 2023-03-31 | 370.20 Cr | 341.42 Cr | 28.78 Cr | 0.0777 | 3.32 Cr | 9.25 Cr | 15.10 Cr | 1.27 Cr | 0.80 | 25.95 Cr | 0.0034 |
| 2022-03-31 | 447.37 Cr | 392.68 Cr | 54.69 Cr | 0.1222 | 2.96 Cr | 7.77 Cr | 35.57 Cr | 19.66 Cr | 12.42 | 45.18 Cr | 0.0439 |
| 2021-03-31 | 379.80 Cr | 282.13 Cr | 97.67 Cr | 0.2572 | 2.25 Cr | 6.24 Cr | 44.45 Cr | 27.97 Cr | 17.67 | 55.02 Cr | 0.0736 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.59 Cr | 366.42 Cr | 217.44 Cr | 148.9790 Cr | 96.23 Cr | 93.64 Cr | 138.80 Cr | 133.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 191.5994 Cr |
| 2024-03-31 | 1.19 Cr | 333.70 Cr | 197.91 Cr | 135.7930 Cr | 106.99 Cr | 105.81 Cr | 123.64 Cr | 129.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 164.0611 Cr |
| 2023-03-31 | 2.68 Cr | 359.63 Cr | 207.67 Cr | 151.9562 Cr | 88.55 Cr | 85.87 Cr | 137.47 Cr | 134.43 Cr | 0.26 Cr | 0.00 Cr | 0.00 Cr | 165.3575 Cr |
| 2022-03-31 | 1.95 Cr | 328.43 Cr | 177.86 Cr | 150.5614 Cr | 87.90 Cr | 85.96 Cr | 117.11 Cr | 129.21 Cr | 10.49 Cr | 0.00 Cr | 0.00 Cr | 130.1133 Cr |
| 2021-03-31 | 0.58 Cr | 264.11 Cr | 133.32 Cr | 130.7860 Cr | 69.71 Cr | 69.12 Cr | 58.59 Cr | 117.54 Cr | 0.00 Cr | 0.00 Cr | 0.22 Cr | 109.0776 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 42.5941 Cr | -19.4724 Cr | -21.7124 Cr | 22.3929 Cr | 1.4093 Cr | 2.5889 Cr | -20.2012 Cr | 6.7207 Cr | -6.7094 Cr | 0.0000 Cr | -15.1621 Cr |
| 2024-03-31 | 3.9126 Cr | -11.8274 Cr | 5.2267 Cr | -7.9201 Cr | -1.5011 Cr | 1.1796 Cr | -11.8327 Cr | -9.0717 Cr | 12.4869 Cr | 0.0000 Cr | 16.8876 Cr |
| 2023-03-31 | 39.5231 Cr | -22.1723 Cr | -16.6171 Cr | 11.6094 Cr | 0.7338 Cr | 2.6807 Cr | -27.9137 Cr | 2.2138 Cr | -3.8658 Cr | 0.0000 Cr | -20.3609 Cr |
| 2022-03-31 | 25.7091 Cr | -27.3257 Cr | 2.9793 Cr | -1.9599 Cr | 1.3627 Cr | 1.9469 Cr | -27.6690 Cr | 27.7330 Cr | 14.1411 Cr | 0.0000 Cr | -58.5180 Cr |
| 2021-03-31 | 27.5497 Cr | -31.2853 Cr | 2.6983 Cr | -3.8864 Cr | -1.0373 Cr | 0.5918 Cr | -31.4361 Cr | 39.5191 Cr | 13.4421 Cr | 0.0000 Cr | 6.2551 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 58.49 Cr | 56.82 Cr | 1.66 Cr | 0.0284 | -5.89 Cr | -9.84 Cr | -6.21 | -1.32 Cr | -0.1682 |
| 2025-09-30 | 49.26 Cr | 33.06 Cr | 16.20 Cr | 0.3289 | -7.47 Cr | -7.35 Cr | -4.64 | -2.81 Cr | -0.1491 |
| 2025-06-30 | 57.21 Cr | 45.73 Cr | 11.48 Cr | 0.2007 | -8.95 Cr | -13.80 Cr | -8.72 | -4.48 Cr | -0.2412 |
| 2025-03-31 | 72.78 Cr | 35.36 Cr | 37.41 Cr | 0.5141 | 5.45 Cr | 0.06 Cr | 0.04 | 9.61 Cr | 0.0008 |
| 2024-12-31 | 88.55 Cr | 50.93 Cr | 37.62 Cr | 0.4249 | 4.72 Cr | 1.29 Cr | 0.81 | 8.91 Cr | 0.0145 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 3.38 Cr | 6.30 Cr | 9.67 Cr | 18.10 Cr | 116.94 Cr | 152.78 Cr | 132.18 Cr | 316.72 Cr | 189.15 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 2.59 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -148.98 Cr |
| 2025-03-31 | 2.59 Cr | 0.00 Cr | 2.59 Cr | 40.17 Cr | 138.80 Cr | 198.98 Cr | 133.60 Cr | 366.42 Cr | 217.44 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 6.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -147.97 Cr |
| 2024-09-30 | 6.09 Cr | 0.00 Cr | 6.09 Cr | 26.74 Cr | 142.95 Cr | 200.97 Cr | 130.79 Cr | 364.11 Cr | 216.14 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -13.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 1.29 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 2.69 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2.68 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,812.80 | ₹4,349,514,433,616.00 | ₹3,298,187.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,372.00 | ₹1,691,565,791,760.00 | ₹298,134.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,427.80 | ₹1,498,568,719,232.00 | ₹373,853.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,314.60 | ₹1,094,510,791,983.00 | ₹2,328,593.00 |
| Lupin Limited | LUPIN | ₹2,337.40 | ₹1,068,292,308,200.00 | ₹1,118,737.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹923.10 | ₹928,854,596,169.00 | ₹548,985.00 |
| Mankind Pharma Limited | MANKIND | ₹2,237.70 | ₹923,733,909,614.00 | ₹1,043,890.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,285.90 | ₹746,852,807,016.00 | ₹2,197,557.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,616.50 | ₹671,536,822,500.00 | ₹127,559.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,225.80 | ₹628,122,560,672.00 | ₹1,554,299.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,038.00 | ₹560,371,132,116.00 | ₹1,367,251.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,491.20 | ₹378,323,729,882.00 | ₹56,999.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,999.90 | ₹374,794,378,438.00 | ₹123,025.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,117.40 | ₹339,967,004,084.00 | ₹706,890.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,567.80 | ₹297,211,828,212.00 | ₹871,597.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,815.50 | ₹220,387,500,000.00 | ₹3,477.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,327.40 | ₹215,692,105,131.00 | ₹576,727.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹1,039.20 | ₹186,130,976,904.00 | ₹2,029,982.00 |
| Eris Lifesciences Limited | ERIS | ₹1,351.10 | ₹184,042,641,430.00 | ₹100,690.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,597.00 | ₹161,618,111,733.00 | ₹24,766.00 |
| Granules India Limited | GRANULES | ₹581.30 | ₹141,063,489,700.00 | ₹712,670.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹712.35 | ₹140,021,741,381.00 | ₹50,451.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹812.35 | ₹128,651,664,788.00 | ₹293,109.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,684.10 | ₹128,011,297,234.00 | ₹43,345.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹940.65 | ₹115,451,618,400.00 | ₹42,515.00 |
| Cohance Lifesciences Limited | COHANCE | ₹295.60 | ₹113,086,846,584.00 | ₹907,550.00 |
| Viyash Scientific Limited | VIYASH | ₹197.45 | ₹86,151,137,188.00 | ₹1,162,070.00 |
| Procter & Gamble Health Limited | PGHL | ₹4,892.10 | ₹81,205,836,682.00 | ₹11,986.00 |
| Strides Pharma Science Limited | STAR | ₹872.90 | ₹80,457,562,051.00 | ₹160,822.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹500.60 | ₹76,642,890,235.00 | ₹265,090.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹338.65 | ₹66,233,781,988.00 | ₹758,443.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹686.70 | ₹62,254,676,925.00 | ₹118,363.00 |
| FDC Limited | FDC | ₹378.05 | ₹61,550,352,256.00 | ₹52,686.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹124.37 | ₹40,360,749,900.00 | ₹1,617,219.00 |
| Innova Captab Limited | INNOVACAP | ₹703.35 | ₹40,249,153,812.00 | ₹21,279.00 |
| Suven Life Sciences Limited | SUVEN | ₹144.43 | ₹33,500,801,218.00 | ₹421,279.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹301.45 | ₹32,847,579,134.00 | ₹64,137.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹353.45 | ₹32,259,381,500.00 | ₹243,536.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,908.60 | ₹31,566,364,029.00 | ₹7,443.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹289.65 | ₹29,046,827,863.00 | ₹71,884.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹509.55 | ₹25,843,919,953.00 | ₹191,509.00 |
Key Executives
Gender: Not Specified
Year Born: 1979
Gender: male
Year Born: 1974
Gender: Not Specified
Year Born: 1980
Gender: male
Year Born: 1951
Gender: male
Year Born: 1953
Gender: male
Year Born: 2000
Gender: female
Year Born: 1993
Gender: female
Year Born: 1985
Gender: female
Year Born: 1979
FAQs about Mangalam Drugs & Organics Limited
The CEO is Govardhan Murlidhar Dhoot.
The current price is ₹27.88.
The range is ₹22.8-95.
The market capitalization is ₹44.13 crores.
The P/E ratio is -1.43.
The company operates in the Healthcare sector.
Overview of Mangalam Drugs & Organics Limited (ISIN: INE584F01014) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹44.13 crores and an average daily volume of 163,212 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.